Difficulty: Medium
Average Score: 90%
Practice
What is the most appropriate first step in treating a patient with acute asthma exacerbation?
Correct answer
C
Rationale
In the context of treating a patient with acute asthma exacerbation, the most appropriate first step is to administer a short-acting beta-agonist (SABA), which is reflected in option C. This is because SABAs, such as albuterol, work quickly to dilate the airways and provide rapid relief of bronchoconstriction, helping to alleviate acute symptoms like shortness of breath and wheezing.
Providing oxygen therapy (option B) is important in managing asthma exacerbation, but it typically follows the administration of a bronchodilator like a SABA. Oxygen therapy helps to ensure adequate oxygenation in cases where the patient may be hypoxic due to respiratory distress.
Administering oral corticosteroids (option A) is also an essential component of asthma management, especially in preventing future exacerbations and reducing airway inflammation. However, in the acute setting, bronchodilators like SABAs take precedence due to their immediate bronchodilatory effects.
Giving intravenous fluids (option D) is not typically indicated as a first-line treatment for acute asthma exacerbation. Fluids may be needed if the patient is dehydrated or in shock, but addressing the airway obstruction and bronchoconstriction with a bronchodilator is the primary focus in the initial management of asthma exacerbation.
In an educational context, understanding the stepwise approach to managing acute asthma exacerbation is crucial for healthcare providers involved in the care of patients with asthma. Recognizing the importance of prompt administration of bronchodilators like SABAs can help improve patient outcomes and reduce the risk of complications associated with uncontrolled asthma exacerbations.
Providing oxygen therapy (option B) is important in managing asthma exacerbation, but it typically follows the administration of a bronchodilator like a SABA. Oxygen therapy helps to ensure adequate oxygenation in cases where the patient may be hypoxic due to respiratory distress.
Administering oral corticosteroids (option A) is also an essential component of asthma management, especially in preventing future exacerbations and reducing airway inflammation. However, in the acute setting, bronchodilators like SABAs take precedence due to their immediate bronchodilatory effects.
Giving intravenous fluids (option D) is not typically indicated as a first-line treatment for acute asthma exacerbation. Fluids may be needed if the patient is dehydrated or in shock, but addressing the airway obstruction and bronchoconstriction with a bronchodilator is the primary focus in the initial management of asthma exacerbation.
In an educational context, understanding the stepwise approach to managing acute asthma exacerbation is crucial for healthcare providers involved in the care of patients with asthma. Recognizing the importance of prompt administration of bronchodilators like SABAs can help improve patient outcomes and reduce the risk of complications associated with uncontrolled asthma exacerbations.